Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate.

BACKGROUND Cardiac reperfusion initiates release of inositol 1,4,5-triphosphate [Ins(1,4,5)P3] and arrhythmogenesis via norepinephrine stimulation of alpha1-adrenergic receptors. The present study examines arrhythmogenic effects of thrombin-stimulated Ins(1,4,5)P3 release under these conditions. METHODS AND RESULTS [3H]Ins(1,4,5)P3 release was measured in [3H]inositol-labeled rat hearts by high-performance liquid chromatography. Arrhythmia studies were performed in buffer-perfused rat hearts. Two-minute reperfusion after 20 minutes of global ischemia increased [3H]Ins(1,4,5)P3 from 1123 +/- 77 to 2238 +/- 44 cpm/mg tissue. No increase was observed in catecholamine-depleted hearts (755 +/- 89 cpm/mg). The addition of thrombin (5 IU/mL) or thrombin receptor agonist peptide (TRAP(1-6), 50 micromol/L) restored the reperfusion Ins(1,4,5)P3 response (thrombin, 1518 +/- 68 cpm/mg and TRAP(1-6), 1755 +/- 128 cpm/mg). Ins(1,4,5)P3 release initiated by norepinephrine or thrombin was inhibited by gentamicin (150 micromol/L; 986 +/- 52 and 868 +/- 125 cpm/mg, respectively). The thrombin response was inhibited by the phospholipase C inhibitor U-73122 (5 micromol/L; 394 +/- 59 cpm/mg) but not by its inactive isomer U-73343. The norepinephrine response was not inhibited by U-73122 (2126 +/- 74 cpm/mg). Ventricular tachycardia and ventricular fibrillation were observed in intact hearts but not in hearts from catecholamine-depleted rats (ventricular fibrillation duration, 110 +/- 19 versus 0 +/- 0 seconds). The addition of thrombin or TRAP(1-6) increased arrhythmias in catecholamine-depleted hearts (112 +/- 32 and 89 +/- 28 seconds, respectively). Gentamicin and U-73122 but not U-73343 prevented thrombin-induced arrhythmias. Gentamicin inhibited norepinephrine-initiated arrhythmias, but U-73122 was ineffective. CONCLUSIONS This study demonstrates that the development of reperfusion arrhythmias under these conditions depends on the release of Ins(1,4,5)P3.

[1]  T. Nosek,et al.  Inositol trisphosphate enhances Ca2+ oscillations but not Ca2+-induced Ca2+ release from cardiac sarcoplasmic reticulum , 1991, Pflügers Archiv.

[2]  E. Woodcock,et al.  The inositol phosphate response to thrombin in rat right atria differs from the response to noradrenaline. , 1995, European journal of pharmacology.

[3]  A. Dart,et al.  Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. , 1995, Circulation.

[4]  P. Corr,et al.  Activation of thrombin receptor increases intracellular Na+ during myocardial ischemia. , 1995, The American journal of physiology.

[5]  A. Dart,et al.  Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. , 1995, Circulation research.

[6]  E. Woodcock,et al.  Inositol phosphate release and metabolism in rat left atria. , 1995, Circulation research.

[7]  N. Dhanasekaran,et al.  Protein kinase C-dependent and -independent activation of Na+/H+ exchanger by G alpha 12 class of G proteins. , 1994, The Journal of biological chemistry.

[8]  R. Holz,et al.  Neomycin and spermine have similar effects on secretion and phosphoinositide metabolism in ATP-depleted permeabilized adrenal chromaffin cells. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[9]  P. Corr,et al.  Thrombin-induced release of lysophosphatidylcholine from endothelial cells. , 1993, The Journal of biological chemistry.

[10]  M. Berridge.  Inositol trisphosphate and calcium signalling , 1993, Nature.

[11]  A. Pappano,et al.  Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. , 1991, Circulation research.

[12]  A. Sorisky,et al.  "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. , 1991, The Journal of biological chemistry.

[13]  W. Moolenaar.  G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[14]  M. Rosen,et al.  Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. , 1991, Circulation Research.

[15]  F. Fitzpatrick,et al.  Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. , 1990, The Journal of pharmacology and experimental therapeutics.

[16]  G. Kucera,et al.  Human platelets form 3-phosphorylated phosphoinositides in response to alpha-thrombin, U46619, or GTP gamma S. , 1990, The Journal of biological chemistry.

[17]  S. Shears,et al.  Metabolism of the inositol phosphates produced upon receptor activation. , 1989, The Biochemical journal.

[18]  S. McLaughlin,et al.  Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2). , 1989, Biochimica et biophysica acta.

[19]  R. Campbell,et al.  The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. , 1988, Cardiovascular research.